{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:27:05Z","timestamp":1791307625447,"version":"4.3.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T00:00:00Z","timestamp":1477353600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/K10019494\/1"],"award-info":[{"award-number":["MR\/K10019494\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["L016354"],"award-info":[{"award-number":["L016354"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT086755MA"],"award-info":[{"award-number":["WT086755MA"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["R24AA012885"],"award-info":[{"award-number":["R24AA012885"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["UA1AA018663"],"award-info":[{"award-number":["UA1AA018663"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.ymthe.2016.10.004","type":"journal-article","created":{"date-parts":[[2017,1,5]],"date-time":"2017-01-05T16:46:56Z","timestamp":1483634816000},"page":"218-231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A"],"prefix":"10.1016","volume":"25","author":[{"given":"M\u00fcjdat","family":"Zeybel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saimir","family":"Luli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sabater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Oakley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agata","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Moran Salvador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Sharkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.K.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma Sharan","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar J.","family":"Mendivil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek A.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2016.10.004_bib1","first-page":"96","article-title":"Fibrosis--A Common Pathway to Organ Injury and Failure","volume":"373","author":"Rockey","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"Suppl 1","key":"10.1016\/j.ymthe.2016.10.004_bib2","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jhep.2008.01.022","article-title":"Novel advancements in the management of hepatocellular carcinoma in 2008","volume":"48","author":"Llovet","year":"2008","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"171","author":"Azuma","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ymthe.2016.10.004_bib4","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/path.1427","article-title":"The myofibroblast in wound healing and fibrocontractive diseases","volume":"200","author":"Gabbiani","year":"2003","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib5","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","article-title":"The myofibroblast: one function, multiple origins","volume":"170","author":"Hinz","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib6","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MNH.0b013e328344c3d4","article-title":"Mechanisms of fibrosis: the role of the pericyte","volume":"20","author":"Schrimpf","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ymthe.2016.10.004_bib7","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.humpath.2009.02.020","article-title":"Direct contribution of epithelium to organ fibrosis: epithelial-mesenchymal transition","volume":"40","author":"Guarino","year":"2009","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib8","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10495-005-1055-4","article-title":"The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis","volume":"10","author":"Elsharkawy","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.ymthe.2016.10.004_bib9","doi-asserted-by":"crossref","first-page":"9448","DOI":"10.1073\/pnas.1201840109","article-title":"Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis","volume":"109","author":"Kisseleva","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2016.10.004_bib10","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/ncomms3823","article-title":"Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology","volume":"4","author":"Mederacke","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2016.10.004_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/mi.2013.87","article-title":"IL-1\u03b1 released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblasts","volume":"7","author":"Suwara","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jhep.2015.11.024","article-title":"Hepatic stellate cell transdifferentiation involves genome-wide remodeling of the DNA methylation landscape","volume":"64","author":"Page","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/hep.25754","article-title":"Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation","volume":"56","author":"Perugorria","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2016.10.004_bib14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1053\/j.gastro.2009.10.002","article-title":"MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis","volume":"138","author":"Mann","year":"2010","journal-title":"Gastroenterology."},{"key":"10.1016\/j.ymthe.2016.10.004_bib15","doi-asserted-by":"crossref","first-page":"11392","DOI":"10.1074\/jbc.M310284200","article-title":"Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells","volume":"279","author":"Hazra","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ymthe.2016.10.004_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2016.10.004_bib17","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1158\/1535-7163.MCT-13-0773","article-title":"Selective inhibition of EZH2 by EPZ-6438 leads to potent antitumor activity in EZH2-mutant non-Hodgkin lymphoma","volume":"13","author":"Knutson","year":"2014","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2016.10.004_bib18","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.ymthe.2016.10.004_bib19","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1096\/fj.13-241760","article-title":"A\u00a0central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis","volume":"28","author":"Coward","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.ymthe.2016.10.004_bib20","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jhep.2016.03.021","article-title":"A new fluorescence-based optical imaging method to non-invasively monitor hepatic myofibroblasts in\u00a0vivo","volume":"65","author":"Luli","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt1396","article-title":"Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone","volume":"26","author":"Sato","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2011.12.023","article-title":"Effects of interferon-gamma liposomes targeted to platelet-derived growth factor receptor-beta on hepatic fibrosis in rats","volume":"159","author":"Li","year":"2012","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2016.10.004_bib23","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1124\/jpet.107.122481","article-title":"Cyclic Arg-Gly-Asp peptide-labeled liposomes for targeting drug therapy of hepatic fibrosis in rats","volume":"322","author":"Du","year":"2007","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ymthe.2016.10.004_bib24","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.3748\/wjg.v18.i31.4199","article-title":"Oxymatrine liposome attenuates hepatic fibrosis via targeting hepatic stellate cells","volume":"18","author":"Chai","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1053\/gast.2001.27188","article-title":"Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats","volume":"121","author":"Wright","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2016.10.004_bib26","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0168-3659(01)00312-1","article-title":"Targeted delivery of antisense oligonucleotides in cancer","volume":"74","author":"Pastorino","year":"2001","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2016.10.004_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jconrel.2013.04.029","article-title":"Novel phage display-derived neuroblastoma-targeting peptides potentiate the effect of drug nanocarriers in preclinical settings","volume":"170","author":"Loi","year":"2013","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2016.10.004_bib28","first-page":"86","article-title":"Doxorubicin-loaded Fab\u2019 fragments of anti-disialoganglioside immunoliposomes selectively inhibit the growth and dissemination of human neuroblastoma in nude mice","volume":"63","author":"Pastorino","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ymthe.2016.10.004_bib29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jconrel.2013.06.015","article-title":"Enhanced anti-tumor and anti-angiogenic efficacy of a novel liposomal fenretinide on human neuroblastoma","volume":"170","author":"Di Paolo","year":"2013","journal-title":"J.\u00a0Control. Release"},{"key":"10.1016\/j.ymthe.2016.10.004_bib30","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1038\/mt.2011.142","article-title":"Selective therapeutic targeting of the anaplastic lymphoma kinase with liposomal siRNA induces apoptosis and inhibits angiogenesis in neuroblastoma","volume":"19","author":"Di Paolo","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2016.10.004_bib31","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/mt.2011.54","article-title":"Neuroblastoma-targeted nanoparticles entrapping siRNA specifically knockdown ALK","volume":"19","author":"Di Paolo","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2016.10.004_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/j.gastro.2004.10.003","article-title":"Inhibition of inhibitor of kappaB kinases stimulates hepatic stellate cell apoptosis and accelerated recovery from rat liver fibrosis","volume":"128","author":"Oakley","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ymthe.2016.10.004_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cmdc.201402315","article-title":"3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death","volume":"10","author":"Tam","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ymthe.2016.10.004_bib34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"11, Suppl","key":"10.1016\/j.ymthe.2016.10.004_bib35","first-page":"146S","article-title":"Ethanol-induced liver injury: potential roles for egr-1","volume":"29","author":"Pritchard","year":"2005","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.ymthe.2016.10.004_bib36","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.2174\/092986707782793916","article-title":"Ligand-targeted liposomal therapies of neuroblastoma","volume":"14","author":"Pastorino","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ymthe.2016.10.004_bib37","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jhep.2008.01.032","article-title":"Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury","volume":"49","author":"Douglass","year":"2008","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib38","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.jhep.2005.01.028","article-title":"Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells--a potential mechanism for targeting liver anti-fibrotic therapeutics","volume":"42","author":"Elrick","year":"2005","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib39","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/onc.2011.601","article-title":"Epigenetic cancer therapy: rationales, targets and drugs","volume":"31","author":"Rius","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2016.10.004_bib40","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/sj.jid.5700613","article-title":"Formation and function of the myofibroblast during tissue repair","volume":"127","author":"Hinz","year":"2007","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/BOR.0b013e32835b13e1","article-title":"Epigenetic regulation of wound healing and fibrosis","volume":"25","author":"Mann","year":"2013","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib42","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2014.09.033","article-title":"Alcohol directly stimulates epigenetic modifications in hepatic stellate cells","volume":"62","author":"Page","year":"2015","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib43","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/sj.cdd.4401979","article-title":"Regulation of myofibroblast transdifferentiation by DNA methylation and MeCP2: implications for wound healing and fibrogenesis","volume":"14","author":"Mann","year":"2007","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ymthe.2016.10.004_bib44","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/hep.510290328","article-title":"A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture","volume":"29","author":"Niki","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2016.10.004_bib45","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1111\/bph.12590","article-title":"A new histone deacetylase inhibitor improves liver fibrosis in BDL rats through suppression of hepatic stellate cells","volume":"171","author":"Park","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib46","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/liv.12034","article-title":"A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-\u03b2 and vascular endothelial growth factor signalling","volume":"33","author":"Liu","year":"2013","journal-title":"Liver Int."},{"key":"10.1016\/j.ymthe.2016.10.004_bib47","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.23334","article-title":"Chronic administration of valproic acid inhibits activation of mouse hepatic stellate cells in\u00a0vitro and in\u00a0vivo","volume":"51","author":"Mannaerts","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2016.10.004_bib48","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1167\/iovs.14-16258","article-title":"Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy","volume":"56","author":"He","year":"2015","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ymthe.2016.10.004_bib49","doi-asserted-by":"crossref","first-page":"e88685","DOI":"10.1371\/journal.pone.0088685","article-title":"Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22","volume":"9","author":"Feng","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ymthe.2016.10.004_bib50","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/CIRCRESAHA.115.306721","article-title":"Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure","volume":"117","author":"Mayer","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.ymthe.2016.10.004_bib51","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijbiomac.2015.10.076","article-title":"MeCP2 regulation of cardiac fibroblast proliferation and fibrosis by down-regulation of DUSP5","volume":"82","author":"Tao","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib52","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.ajpath.2011.01.002","article-title":"Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis","volume":"178","author":"Hu","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ymthe.2016.10.004_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/aps.2013.161","article-title":"EZH2: biology, disease, and structure-based drug discovery","volume":"35","author":"Tan","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ymthe.2016.10.004_bib54","first-page":"175","article-title":"Diverse involvement of EZH2 in cancer epigenetics","volume":"7","author":"V\u00f6lkel","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.ymthe.2016.10.004_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jb\/mvu054","article-title":"Targeting histone methyltransferase EZH2 as cancer treatment","volume":"156","author":"Kondo","year":"2014","journal-title":"J.\u00a0Biochem."},{"key":"10.1016\/j.ymthe.2016.10.004_bib56","doi-asserted-by":"crossref","first-page":"24154","DOI":"10.3390\/ijms141224154","article-title":"EZH2 down-regulation exacerbates lipid accumulation and inflammation in in\u00a0vitro and in\u00a0vivo NAFLD","volume":"14","author":"Vella","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymthe.2016.10.004_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2015.01.002","article-title":"Targeting histone lysine methylation in cancer","volume":"150","author":"McGrath","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ymthe.2016.10.004_bib58","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ki.2015.291","article-title":"Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expression","volume":"89","author":"Irifuku","year":"2015","journal-title":"Kidney Int."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616453578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616453578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:04:36Z","timestamp":1778616276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616453578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S1525001616453578"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2016.10.004","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Proof-of-Concept for Epigenetic Therapy of Tissue Fibrosis: Inhibition of Liver Fibrosis Progression by 3-Deazaneplanocin A","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2016.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s).","name":"copyright","label":"Copyright"}]}}